背景:妊娠糖尿病(GDM)在全球范围内出现,并且与妇女及其后代的短期和长期健康问题密切相关,如妊娠和分娩并发症分别合并症,2型糖尿病(T2D),代谢综合征以及心血管疾病。在这种背景下,移动健康应用程序(mHealth-Apps)确实为改善GDM管理开辟了新的可能性。因此,我们分析了特定mHealth-App对母婴临床健康相关短期和长期结局的临床有效性.
方法:在Medline(PubMed)进行系统的文献检索,科克伦图书馆,Embase,执行了CINAHL和WebofScience核心收藏数据库以及GoogleScholar。我们选择了2008年至2020年发表的研究,使用特定的mHealth-Apps分析被诊断为GDM的女性。纳入对照临床试验(CCT)和随机对照试验(RCT)。使用有效公共卫生实践项目(EPHPP)工具评估研究质量。
结果:总计,n=6个出版物(n=5个随机对照试验,n=1CCT;n=4中度,n=2弱质量),分析干预组的n=408例GDM患者和对照组的n=405例,包括在内。与对照组相比,空腹血糖,餐后2小时血糖,偏离目标血糖测量,分娩方式(更多的阴道分娩和更少的(紧急)剖宫产)和患者依从性呈现改善趋势.
结论:mHealth-Apps可能会改善与健康相关的结果,尤其是血糖控制,在GDM的管理中。需要更详细地进行进一步的研究。
BACKGROUND: Gestational diabetes mellitus (GDM) emerges worldwide and is closely associated with short- and long-term health issues in women and their offspring, such as pregnancy and birth complications respectively comorbidities, Type 2 Diabetes (T2D), metabolic syndrome as well as cardiovascular diseases. Against this background, mobile health applications (mHealth-Apps) do open up new possibilities to improve the management of GDM. Therefore, we analyzed the clinical effectiveness of specific mHealth-Apps on clinical health-related short and long-term outcomes in mother and child.
METHODS: A systematic literature search in Medline (PubMed), Cochrane Library, Embase, CINAHL and Web of Science Core Collection databases as well as Google Scholar was performed. We selected studies published 2008 to 2020 analyzing women diagnosed with GDM using specific mHealth-Apps. Controlled clinical trials (CCT) and randomized controlled trials (RCT) were included. Study quality was assessed using the Effective Public Health Practice Project (EPHPP) tool.
RESULTS: In total, n = 6 publications (n = 5 RCTs, n = 1 CCT; and n = 4 moderate, n = 2 weak quality), analyzing n = 408 GDM patients in the intervention and n = 405 in the control groups, were included. Compared to control groups, fasting blood glucose, 2-h postprandial blood glucose, off target blood glucose measurements, delivery mode (more vaginal deliveries and fewer (emergency) caesarean sections) and patient compliance showed improving trends.
CONCLUSIONS: mHealth-Apps might improve health-related outcomes, particularly glycemic control, in the management of GDM. Further studies need to be done in more detail.